메뉴 건너뛰기




Volumn 7, Issue , 2010, Pages

Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIBODY; CD4 ANTIGEN; DNA; GLYCOPROTEIN GP 160; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2G12;

EID: 77956855128     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-76     Document Type: Article
Times cited : (30)

References (90)
  • 1
    • 33746763724 scopus 로고    scopus 로고
    • Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
    • 10.1586/14760584.5.3.347, 2716009, 16827619
    • Haynes BF, Montefiori DC. Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. Expert Rev Vaccines 2006, 5:347-363. 10.1586/14760584.5.3.347, 2716009, 16827619.
    • (2006) Expert Rev Vaccines , vol.5 , pp. 347-363
    • Haynes, B.F.1    Montefiori, D.C.2
  • 2
    • 38949170716 scopus 로고    scopus 로고
    • Prospects of HIV Env modification as an approach to HIV vaccine design
    • 10.2174/157016207782418542, 18045108
    • Hu SL, Stamatatos L. Prospects of HIV Env modification as an approach to HIV vaccine design. Curr HIV Res 2007, 5:507-513. 10.2174/157016207782418542, 18045108.
    • (2007) Curr HIV Res , vol.5 , pp. 507-513
    • Hu, S.L.1    Stamatatos, L.2
  • 3
    • 33846172297 scopus 로고    scopus 로고
    • Rational modifications of HIV-1 envelope glycoproteins for immunogen design
    • 10.2174/138161207779313632, 17269929
    • Phogat S, Wyatt R. Rational modifications of HIV-1 envelope glycoproteins for immunogen design. Curr Pharm Des 2007, 13:213-227. 10.2174/138161207779313632, 17269929.
    • (2007) Curr Pharm Des , vol.13 , pp. 213-227
    • Phogat, S.1    Wyatt, R.2
  • 7
    • 33748896583 scopus 로고    scopus 로고
    • Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity
    • 10.1097/01.aids.0000247113.43714.5e, 16988513
    • Braibant M, Brunet S, Costagliola D, Rouzioux C, Agut H, Katinger H, Autran B, Barin F. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity. Aids 2006, 20:1923-1930. 10.1097/01.aids.0000247113.43714.5e, 16988513.
    • (2006) Aids , vol.20 , pp. 1923-1930
    • Braibant, M.1    Brunet, S.2    Costagliola, D.3    Rouzioux, C.4    Agut, H.5    Katinger, H.6    Autran, B.7    Barin, F.8
  • 8
    • 0037083960 scopus 로고    scopus 로고
    • Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1
    • 10.1097/00002030-200202150-00030, 11834970
    • Donners H, Willems B, Beirnaert E, Colebunders R, Davis D, van der Groen G. Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1. Aids 2002, 16:501-503. 10.1097/00002030-200202150-00030, 11834970.
    • (2002) Aids , vol.16 , pp. 501-503
    • Donners, H.1    Willems, B.2    Beirnaert, E.3    Colebunders, R.4    Davis, D.5    van der Groen, G.6
  • 10
    • 33646751914 scopus 로고    scopus 로고
    • Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1
    • 10.1128/JVI.00201-06, 1472127, 16699001
    • Li B, Decker JM, Johnson RW, Bibollet-Ruche F, Wei X, Mulenga J, Allen S, Hunter E, Hahn BH, Shaw GM, Blackwell JL, Derdeyn CA. Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1. J Virol 2006, 80:5211-5218. 10.1128/JVI.00201-06, 1472127, 16699001.
    • (2006) J Virol , vol.80 , pp. 5211-5218
    • Li, B.1    Decker, J.M.2    Johnson, R.W.3    Bibollet-Ruche, F.4    Wei, X.5    Mulenga, J.6    Allen, S.7    Hunter, E.8    Hahn, B.H.9    Shaw, G.M.10    Blackwell, J.L.11    Derdeyn, C.A.12
  • 11
    • 0030901363 scopus 로고    scopus 로고
    • Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals
    • 191523, 9094648
    • Moog C, Fleury HJ, Pellegrin I, Kirn A, Aubertin AM. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. J Virol 1997, 71:3734-3741. 191523, 9094648.
    • (1997) J Virol , vol.71 , pp. 3734-3741
    • Moog, C.1    Fleury, H.J.2    Pellegrin, I.3    Kirn, A.4    Aubertin, A.M.5
  • 12
    • 0030764685 scopus 로고    scopus 로고
    • Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection
    • 10.1086/516508, 9333150
    • Pilgrim AK, Pantaleo G, Cohen OJ, Fink LM, Zhou JY, Zhou JT, Bolognesi DP, Fauci AS, Montefiori DC. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J Infect Dis 1997, 176:924-932. 10.1086/516508, 9333150.
    • (1997) J Infect Dis , vol.176 , pp. 924-932
    • Pilgrim, A.K.1    Pantaleo, G.2    Cohen, O.J.3    Fink, L.M.4    Zhou, J.Y.5    Zhou, J.T.6    Bolognesi, D.P.7    Fauci, A.S.8    Montefiori, D.C.9
  • 13
    • 0037389643 scopus 로고    scopus 로고
    • Rapid evolution of the neutralizing antibody response to HIV type 1 infection
    • 10.1073/pnas.0630530100, 153062, 12644702
    • Richman DD, Wrin T, Little SJ, Petropoulos CJ. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 2003, 100:4144-4149. 10.1073/pnas.0630530100, 153062, 12644702.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 4144-4149
    • Richman, D.D.1    Wrin, T.2    Little, S.J.3    Petropoulos, C.J.4
  • 14
    • 44949262146 scopus 로고    scopus 로고
    • Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses
    • 10.1128/JVI.00389-08, 2395128, 18400850
    • Kraft Z, Strouss K, Sutton WF, Cleveland B, Tso FY, Polacino P, Overbaugh J, Hu SL, Stamatatos L. Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses. J Virol 2008, 82:5912-5921. 10.1128/JVI.00389-08, 2395128, 18400850.
    • (2008) J Virol , vol.82 , pp. 5912-5921
    • Kraft, Z.1    Strouss, K.2    Sutton, W.F.3    Cleveland, B.4    Tso, F.Y.5    Polacino, P.6    Overbaugh, J.7    Hu, S.L.8    Stamatatos, L.9
  • 16
    • 0032546844 scopus 로고    scopus 로고
    • The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens
    • 10.1126/science.280.5371.1884, 9632381
    • Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998, 280:1884-1888. 10.1126/science.280.5371.1884, 9632381.
    • (1998) Science , vol.280 , pp. 1884-1888
    • Wyatt, R.1    Sodroski, J.2
  • 17
    • 0031969423 scopus 로고    scopus 로고
    • Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity
    • 109569, 9557629
    • Parren PW, Mondor I, Naniche D, Ditzel HJ, Klasse PJ, Burton DR, Sattentau QJ. Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity. J Virol 1998, 72:3512-3519. 109569, 9557629.
    • (1998) J Virol , vol.72 , pp. 3512-3519
    • Parren, P.W.1    Mondor, I.2    Naniche, D.3    Ditzel, H.J.4    Klasse, P.J.5    Burton, D.R.6    Sattentau, Q.J.7
  • 18
    • 0030726970 scopus 로고    scopus 로고
    • Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization
    • 10.1084/jem.186.8.1287, 2199094, 9334368
    • Ugolini S, Mondor I, Parren PW, Burton DR, Tilley SA, Klasse PJ, Sattentau QJ. Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization. J Exp Med 1997, 186:1287-1298. 10.1084/jem.186.8.1287, 2199094, 9334368.
    • (1997) J Exp Med , vol.186 , pp. 1287-1298
    • Ugolini, S.1    Mondor, I.2    Parren, P.W.3    Burton, D.R.4    Tilley, S.A.5    Klasse, P.J.6    Sattentau, Q.J.7
  • 20
    • 33744904454 scopus 로고    scopus 로고
    • Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses
    • 10.1128/JVI.00093-06, 1472617, 16731954
    • Deeks SG, Schweighardt B, Wrin T, Galovich J, Hoh R, Sinclair E, Hunt P, McCune JM, Martin JN, Petropoulos CJ, Hecht FM. Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses. J Virol 2006, 80:6155-6164. 10.1128/JVI.00093-06, 1472617, 16731954.
    • (2006) J Virol , vol.80 , pp. 6155-6164
    • Deeks, S.G.1    Schweighardt, B.2    Wrin, T.3    Galovich, J.4    Hoh, R.5    Sinclair, E.6    Hunt, P.7    McCune, J.M.8    Martin, J.N.9    Petropoulos, C.J.10    Hecht, F.M.11
  • 24
    • 77952311370 scopus 로고    scopus 로고
    • The role of antibodies in HIV vaccines
    • 10.1146/annurev-immunol-030409-101256, 20192810
    • Mascola JR, Montefiori DC. The role of antibodies in HIV vaccines. Annu Rev Immunol 2010, 28:413-444. 10.1146/annurev-immunol-030409-101256, 20192810.
    • (2010) Annu Rev Immunol , vol.28 , pp. 413-444
    • Mascola, J.R.1    Montefiori, D.C.2
  • 28
    • 9044241681 scopus 로고    scopus 로고
    • Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
    • 189917, 8551569
    • Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinivasan K, Sodroski J, Moore JP, Katinger H. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 1996, 70:1100-1108. 189917, 8551569.
    • (1996) J Virol , vol.70 , pp. 1100-1108
    • Trkola, A.1    Purtscher, M.2    Muster, T.3    Ballaun, C.4    Buchacher, A.5    Sullivan, N.6    Srinivasan, K.7    Sodroski, J.8    Moore, J.P.9    Katinger, H.10
  • 30
    • 0028865465 scopus 로고
    • Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG
    • 189569, 7474069
    • Trkola A, Pomales AB, Yuan H, Korber B, Maddon PJ, Allaway GP, Katinger H, Barbas CF, Burton DR, Ho DD, et al. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol 1995, 69:6609-6617. 189569, 7474069.
    • (1995) J Virol , vol.69 , pp. 6609-6617
    • Trkola, A.1    Pomales, A.B.2    Yuan, H.3    Korber, B.4    Maddon, P.J.5    Allaway, G.P.6    Katinger, H.7    Barbas, C.F.8    Burton, D.R.9    Ho, D.D.10
  • 34
    • 0027256814 scopus 로고
    • Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
    • 237765, 7685405
    • Thali M, Moore JP, Furman C, Charles M, Ho DD, Robinson J, Sodroski J. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 1993, 67:3978-3988. 237765, 7685405.
    • (1993) J Virol , vol.67 , pp. 3978-3988
    • Thali, M.1    Moore, J.P.2    Furman, C.3    Charles, M.4    Ho, D.D.5    Robinson, J.6    Sodroski, J.7
  • 35
    • 0036436313 scopus 로고    scopus 로고
    • Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies
    • 10.1089/08892220260387959, 12487827
    • Xiang SH, Doka N, Choudhary RK, Sodroski J, Robinson JE. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies. AIDS Res Hum Retroviruses 2002, 18:1207-1217. 10.1089/08892220260387959, 12487827.
    • (2002) AIDS Res Hum Retroviruses , vol.18 , pp. 1207-1217
    • Xiang, S.H.1    Doka, N.2    Choudhary, R.K.3    Sodroski, J.4    Robinson, J.E.5
  • 37
    • 13844255333 scopus 로고    scopus 로고
    • Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41
    • 10.1016/j.immuni.2004.12.011, 15723805
    • Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H, Burton DR, Wilson IA. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 2005, 22:163-173. 10.1016/j.immuni.2004.12.011, 15723805.
    • (2005) Immunity , vol.22 , pp. 163-173
    • Cardoso, R.M.1    Zwick, M.B.2    Stanfield, R.L.3    Kunert, R.4    Binley, J.M.5    Katinger, H.6    Burton, D.R.7    Wilson, I.A.8
  • 38
    • 0034759882 scopus 로고    scopus 로고
    • Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41
    • 10.1128/JVI.75.22.10892-10905.2001, 114669, 11602729
    • Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, Moore JP, Stiegler G, Katinger H, Burton DR, Parren PW. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol 2001, 75:10892-10905. 10.1128/JVI.75.22.10892-10905.2001, 114669, 11602729.
    • (2001) J Virol , vol.75 , pp. 10892-10905
    • Zwick, M.B.1    Labrijn, A.F.2    Wang, M.3    Spenlehauer, C.4    Saphire, E.O.5    Binley, J.M.6    Moore, J.P.7    Stiegler, G.8    Katinger, H.9    Burton, D.R.10    Parren, P.W.11
  • 40
    • 0038076112 scopus 로고    scopus 로고
    • Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions
    • 10.1128/JVI.77.10.5678-5684.2003, 154040, 12719560
    • Binley JM, Cayanan CS, Wiley C, Schulke N, Olson WC, Burton DR. Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions. J Virol 2003, 77:5678-5684. 10.1128/JVI.77.10.5678-5684.2003, 154040, 12719560.
    • (2003) J Virol , vol.77 , pp. 5678-5684
    • Binley, J.M.1    Cayanan, C.S.2    Wiley, C.3    Schulke, N.4    Olson, W.C.5    Burton, D.R.6
  • 41
    • 33644752818 scopus 로고    scopus 로고
    • Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma
    • 10.1128/JVI.80.6.3030-3041.2006, 1395451, 16501112
    • Yuste E, Sanford HB, Carmody J, Bixby J, Little S, Zwick MB, Greenough T, Burton DR, Richman DD, Desrosiers RC, Johnson WE. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma. J Virol 2006, 80:3030-3041. 10.1128/JVI.80.6.3030-3041.2006, 1395451, 16501112.
    • (2006) J Virol , vol.80 , pp. 3030-3041
    • Yuste, E.1    Sanford, H.B.2    Carmody, J.3    Bixby, J.4    Little, S.5    Zwick, M.B.6    Greenough, T.7    Burton, D.R.8    Richman, D.D.9    Desrosiers, R.C.10    Johnson, W.E.11
  • 43
    • 0025267919 scopus 로고
    • Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera
    • 10.1097/00002030-199002000-00002, 2328092
    • Albert J, Abrahamsson B, Nagy K, Aurelius E, Gaines H, Nystrom G, Fenyo EM. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. Aids 1990, 4:107-112. 10.1097/00002030-199002000-00002, 2328092.
    • (1990) Aids , vol.4 , pp. 107-112
    • Albert, J.1    Abrahamsson, B.2    Nagy, K.3    Aurelius, E.4    Gaines, H.5    Nystrom, G.6    Fenyo, E.M.7
  • 45
    • 49149118421 scopus 로고    scopus 로고
    • Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection
    • 10.1128/JVI.00757-08, 2519599, 18524815
    • Bunnik EM, Pisas L, van Nuenen AC, Schuitemaker H. Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J Virol 2008, 82:7932-7941. 10.1128/JVI.00757-08, 2519599, 18524815.
    • (2008) J Virol , vol.82 , pp. 7932-7941
    • Bunnik, E.M.1    Pisas, L.2    van Nuenen, A.C.3    Schuitemaker, H.4
  • 46
    • 38849090714 scopus 로고    scopus 로고
    • The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection
    • 10.1128/JVI.02187-07, 2258729, 18057243
    • Moore PL, Gray ES, Choge IA, Ranchobe N, Mlisana K, Abdool Karim SS, Williamson C, Morris L. The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection. J Virol 2008, 82:1860-1869. 10.1128/JVI.02187-07, 2258729, 18057243.
    • (2008) J Virol , vol.82 , pp. 1860-1869
    • Moore, P.L.1    Gray, E.S.2    Choge, I.A.3    Ranchobe, N.4    Mlisana, K.5    Abdool Karim, S.S.6    Williamson, C.7    Morris, L.8
  • 47
  • 49
    • 33846552274 scopus 로고    scopus 로고
    • Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection
    • 10.1128/JVI.01839-06, 1797511, 17079307
    • Rong R, Bibollet-Ruche F, Mulenga J, Allen S, Blackwell JL, Derdeyn CA. Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection. J Virol 2007, 81:1350-1359. 10.1128/JVI.01839-06, 1797511, 17079307.
    • (2007) J Virol , vol.81 , pp. 1350-1359
    • Rong, R.1    Bibollet-Ruche, F.2    Mulenga, J.3    Allen, S.4    Blackwell, J.L.5    Derdeyn, C.A.6
  • 50
    • 34249789875 scopus 로고    scopus 로고
    • Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1
    • 10.1128/JVI.00257-07, 1900276, 17360739
    • Rong R, Gnanakaran S, Decker JM, Bibollet-Ruche F, Taylor J, Sfakianos JN, Mokili JL, Muldoon M, Mulenga J, Allen S, Hahn BH, Shaw GM, Blackwell JL, Korber BT, Hunter E, Derdeyn CA. Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. J Virol 2007, 81:5658-5668. 10.1128/JVI.00257-07, 1900276, 17360739.
    • (2007) J Virol , vol.81 , pp. 5658-5668
    • Rong, R.1    Gnanakaran, S.2    Decker, J.M.3    Bibollet-Ruche, F.4    Taylor, J.5    Sfakianos, J.N.6    Mokili, J.L.7    Muldoon, M.8    Mulenga, J.9    Allen, S.10    Hahn, B.H.11    Shaw, G.M.12    Blackwell, J.L.13    Korber, B.T.14    Hunter, E.15    Derdeyn, C.A.16
  • 53
    • 0038082126 scopus 로고    scopus 로고
    • Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1
    • 10.1128/JVI.77.14.8061-8071.2003, 161940, 12829845
    • Bouma P, Leavitt M, Zhang PF, Sidorov IA, Dimitrov DS, Quinnan GV. Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1. J Virol 2003, 77:8061-8071. 10.1128/JVI.77.14.8061-8071.2003, 161940, 12829845.
    • (2003) J Virol , vol.77 , pp. 8061-8071
    • Bouma, P.1    Leavitt, M.2    Zhang, P.F.3    Sidorov, I.A.4    Dimitrov, D.S.5    Quinnan, G.V.6
  • 54
    • 0030025979 scopus 로고    scopus 로고
    • Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells
    • 189949, 8551601
    • Carrillo A, Ratner L. Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells. J Virol 1996, 70:1310-1316. 189949, 8551601.
    • (1996) J Virol , vol.70 , pp. 1310-1316
    • Carrillo, A.1    Ratner, L.2
  • 55
    • 0033033625 scopus 로고    scopus 로고
    • Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation
    • 112584, 10364275
    • Cheng-Mayer C, Brown A, Harouse J, Luciw PA, Mayer AJ. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J Virol 1999, 73:5294-5300. 112584, 10364275.
    • (1999) J Virol , vol.73 , pp. 5294-5300
    • Cheng-Mayer, C.1    Brown, A.2    Harouse, J.3    Luciw, P.A.4    Mayer, A.J.5
  • 56
    • 0028322510 scopus 로고
    • Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4
    • 10.1007/BF01310789, 7832633
    • Gram GJ, Hemming A, Bolmstedt A, Jansson B, Olofsson S, Akerblom L, Nielsen JO, Hansen JE. Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Arch Virol 1994, 139:253-261. 10.1007/BF01310789, 7832633.
    • (1994) Arch Virol , vol.139 , pp. 253-261
    • Gram, G.J.1    Hemming, A.2    Bolmstedt, A.3    Jansson, B.4    Olofsson, S.5    Akerblom, L.6    Nielsen, J.O.7    Hansen, J.E.8
  • 57
    • 0028293281 scopus 로고
    • Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization
    • 236701, 8139010
    • Koito A, Harrowe G, Levy JA, Cheng-Mayer C. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. J Virol 1994, 68:2253-2259. 236701, 8139010.
    • (1994) J Virol , vol.68 , pp. 2253-2259
    • Koito, A.1    Harrowe, G.2    Levy, J.A.3    Cheng-Mayer, C.4
  • 58
    • 0035100868 scopus 로고    scopus 로고
    • Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops
    • 10.1128/JVI.75.7.3435-3443.2001, 114136, 11238869
    • Kolchinsky P, Kiprilov E, Bartley P, Rubinstein R, Sodroski J. Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops. J Virol 2001, 75:3435-3443. 10.1128/JVI.75.7.3435-3443.2001, 114136, 11238869.
    • (2001) J Virol , vol.75 , pp. 3435-3443
    • Kolchinsky, P.1    Kiprilov, E.2    Bartley, P.3    Rubinstein, R.4    Sodroski, J.5
  • 59
    • 0035162494 scopus 로고    scopus 로고
    • Evolutionary and immunological implications of contemporary HIV-1 variation
    • 10.1093/bmb/58.1.19, 11714622
    • Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull 2001, 58:19-42. 10.1093/bmb/58.1.19, 11714622.
    • (2001) Br Med Bull , vol.58 , pp. 19-42
    • Korber, B.1    Gaschen, B.2    Yusim, K.3    Thakallapally, R.4    Kesmir, C.5    Detours, V.6
  • 60
    • 0030694769 scopus 로고    scopus 로고
    • The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism
    • 10.1089/aid.1997.13.1291, 9339846
    • Morikita T, Maeda Y, Fujii S, Matsushita S, Obaru K, Takatsuki K. The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism. AIDS Res Hum Retroviruses 1997, 13:1291-1299. 10.1089/aid.1997.13.1291, 9339846.
    • (1997) AIDS Res Hum Retroviruses , vol.13 , pp. 1291-1299
    • Morikita, T.1    Maeda, Y.2    Fujii, S.3    Matsushita, S.4    Obaru, K.5    Takatsuki, K.6
  • 61
    • 0028321596 scopus 로고
    • Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers
    • 10.1172/JCI117260, 294468, 7515393
    • Pincus SH, Messer KG, Nara PL, Blattner WA, Colclough G, Reitz M. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers. J Clin Invest 1994, 93:2505-2513. 10.1172/JCI117260, 294468, 7515393.
    • (1994) J Clin Invest , vol.93 , pp. 2505-2513
    • Pincus, S.H.1    Messer, K.G.2    Nara, P.L.3    Blattner, W.A.4    Colclough, G.5    Reitz, M.6
  • 62
    • 0035035296 scopus 로고    scopus 로고
    • Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein
    • 10.1128/JVI.75.11.5230-5239.2001, 114929, 11333905
    • Edwards TG, Hoffman TL, Baribaud F, Wyss S, LaBranche CC, Romano J, Adkinson J, Sharron M, Hoxie JA, Doms RW. Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. J Virol 2001, 75:5230-5239. 10.1128/JVI.75.11.5230-5239.2001, 114929, 11333905.
    • (2001) J Virol , vol.75 , pp. 5230-5239
    • Edwards, T.G.1    Hoffman, T.L.2    Baribaud, F.3    Wyss, S.4    LaBranche, C.C.5    Romano, J.6    Adkinson, J.7    Sharron, M.8    Hoxie, J.A.9    Doms, R.W.10
  • 63
    • 0035038932 scopus 로고    scopus 로고
    • Determination of essential amino acids involved in the CD4-independent tropism of the X4 human immunodeficiency virus type 1 m7NDK isolate: role of potential N glycosylations in the C2 and V3 regions of gp120
    • 10.1128/JVI.75.11.5425-5428.2001, 114953, 11333929
    • Dumonceaux J, Goujon C, Joliot V, Briand P, Hazan U. Determination of essential amino acids involved in the CD4-independent tropism of the X4 human immunodeficiency virus type 1 m7NDK isolate: role of potential N glycosylations in the C2 and V3 regions of gp120. J Virol 2001, 75:5425-5428. 10.1128/JVI.75.11.5425-5428.2001, 114953, 11333929.
    • (2001) J Virol , vol.75 , pp. 5425-5428
    • Dumonceaux, J.1    Goujon, C.2    Joliot, V.3    Briand, P.4    Hazan, U.5
  • 64
    • 0034813198 scopus 로고    scopus 로고
    • A human immunodeficiency virus Env inducible transcription system to examine consequences of gp120 expression
    • 10.1016/S0166-0934(01)00373-1, 11576641
    • Joliot V, Goujon C, Dumonceaux J, Renard A, Briand P, Hazan U. A human immunodeficiency virus Env inducible transcription system to examine consequences of gp120 expression. J Virol Methods 2001, 98:145-151. 10.1016/S0166-0934(01)00373-1, 11576641.
    • (2001) J Virol Methods , vol.98 , pp. 145-151
    • Joliot, V.1    Goujon, C.2    Dumonceaux, J.3    Renard, A.4    Briand, P.5    Hazan, U.6
  • 65
    • 55649084842 scopus 로고    scopus 로고
    • The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors
    • 10.1186/1742-4690-5-89, 2576352, 18837996
    • Rossi F, Querido B, Nimmagadda M, Cocklin S, Navas-Martin S, Martin-Garcia J. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors. Retrovirology 2008, 5:89. 10.1186/1742-4690-5-89, 2576352, 18837996.
    • (2008) Retrovirology , vol.5 , pp. 89
    • Rossi, F.1    Querido, B.2    Nimmagadda, M.3    Cocklin, S.4    Navas-Martin, S.5    Martin-Garcia, J.6
  • 66
    • 0034631503 scopus 로고    scopus 로고
    • Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?
    • 10.1016/S0140-6736(00)02360-6, 10885368
    • Esparza J, Bhamarapravati N. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?. Lancet 2000, 355:2061-2066. 10.1016/S0140-6736(00)02360-6, 10885368.
    • (2000) Lancet , vol.355 , pp. 2061-2066
    • Esparza, J.1    Bhamarapravati, N.2
  • 67
    • 0034978733 scopus 로고    scopus 로고
    • Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development
    • 10.1128/JVI.75.13.5721-5729.2001, 114288, 11390574
    • Moore JP, Parren PW, Burton DR. Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. J Virol 2001, 75:5721-5729. 10.1128/JVI.75.13.5721-5729.2001, 114288, 11390574.
    • (2001) J Virol , vol.75 , pp. 5721-5729
    • Moore, J.P.1    Parren, P.W.2    Burton, D.R.3
  • 69
    • 0034796179 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences
    • 75, 10.1128/JVI.75.21.10479-10487.2001, 114623, 11581417
    • Shankarappa R, Chatterjee R, Learn GH, Neogi D, Ding M, Roy P, Ghosh A, Kingsley L, Harrison L, Mullins JI, Gupta P. Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J Virol 2001, 75:10479-10487. 75, 10.1128/JVI.75.21.10479-10487.2001, 114623, 11581417.
    • (2001) J Virol , vol.75 , pp. 10479-10487
    • Shankarappa, R.1    Chatterjee, R.2    Learn, G.H.3    Neogi, D.4    Ding, M.5    Roy, P.6    Ghosh, A.7    Kingsley, L.8    Harrison, L.9    Mullins, J.I.10    Gupta, P.11
  • 70
    • 0001792727 scopus 로고    scopus 로고
    • Recombinant HIV sequences: their role in the global epidemic
    • Los Alamos National Laboratory, Los Alamos, N Mex, Kuiken FB, Hahn CB, Marx P, McCutchan F, Mellors J, Mullins J, Sodroski J, Wolinksy S, Korber B
    • Peeters M. Recombinant HIV sequences: their role in the global epidemic. HIV sequence compendium 2000 Theoretical Biology and Biophysics Group 2000, 39-54. Los Alamos National Laboratory, Los Alamos, N Mex, Kuiken FB, Hahn CB, Marx P, McCutchan F, Mellors J, Mullins J, Sodroski J, Wolinksy S, Korber B.
    • (2000) HIV sequence compendium 2000 Theoretical Biology and Biophysics Group , pp. 39-54
    • Peeters, M.1
  • 71
    • 39749136530 scopus 로고    scopus 로고
    • 4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response
    • 10.1128/JVI.02161-07, 2258954, 18094155
    • Gray ES, Moore PL, Bibollet-Ruche F, Li H, Decker JM, Meyers T, Shaw GM, Morris L. 4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response. J Virol 2008, 82:2367-2375. 10.1128/JVI.02161-07, 2258954, 18094155.
    • (2008) J Virol , vol.82 , pp. 2367-2375
    • Gray, E.S.1    Moore, P.L.2    Bibollet-Ruche, F.3    Li, H.4    Decker, J.M.5    Meyers, T.6    Shaw, G.M.7    Morris, L.8
  • 72
    • 34648816125 scopus 로고    scopus 로고
    • N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization
    • 10.1128/JVI.01106-07, 2045459, 17634239
    • Gray ES, Moore PL, Pantophlet RA, Morris L. N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization. J Virol 2007, 81:10769-10776. 10.1128/JVI.01106-07, 2045459, 17634239.
    • (2007) J Virol , vol.81 , pp. 10769-10776
    • Gray, E.S.1    Moore, P.L.2    Pantophlet, R.A.3    Morris, L.4
  • 73
    • 33645101026 scopus 로고    scopus 로고
    • Molecular analysis of gp41 sequences of HIV type 1 subtype C from India
    • 10.1097/01.qai.0000209898.67007.1a, 16540936
    • Agnihotri KD, Tripathy SP, Jere AP, Kale SM, Paranjape RS. Molecular analysis of gp41 sequences of HIV type 1 subtype C from India. J Acquir Immune Defic Syndr 2006, 41:345-351. 10.1097/01.qai.0000209898.67007.1a, 16540936.
    • (2006) J Acquir Immune Defic Syndr , vol.41 , pp. 345-351
    • Agnihotri, K.D.1    Tripathy, S.P.2    Jere, A.P.3    Kale, S.M.4    Paranjape, R.S.5
  • 74
    • 1542268337 scopus 로고    scopus 로고
    • Genetic analysis of Indian HIV-1 nef: subtyping, variability and implications
    • 10.1016/j.micinf.2003.11.012, 15026015
    • Jere A, Tripathy S, Agnihotri K, Jadhav S, Paranjape R. Genetic analysis of Indian HIV-1 nef: subtyping, variability and implications. Microbes Infect 2004, 6:279-289. 10.1016/j.micinf.2003.11.012, 15026015.
    • (2004) Microbes Infect , vol.6 , pp. 279-289
    • Jere, A.1    Tripathy, S.2    Agnihotri, K.3    Jadhav, S.4    Paranjape, R.5
  • 75
    • 6344241307 scopus 로고    scopus 로고
    • Full-length gag sequences of HIV type 1 subtype C recent seroconverters from Pune, India
    • 10.1089/aid.2004.20.1113, 15585103
    • Kurle S, Tripathy S, Jadhav S, Agnihotri K, Paranjape R. Full-length gag sequences of HIV type 1 subtype C recent seroconverters from Pune, India. AIDS Res Hum Retroviruses 2004, 20:1113-1118. 10.1089/aid.2004.20.1113, 15585103.
    • (2004) AIDS Res Hum Retroviruses , vol.20 , pp. 1113-1118
    • Kurle, S.1    Tripathy, S.2    Jadhav, S.3    Agnihotri, K.4    Paranjape, R.5
  • 77
    • 34547930926 scopus 로고    scopus 로고
    • Genetic diversity of HIV type 1 subtype C env gene sequences from India
    • 10.1089/aid.2007.0036, 17678478
    • Khan IF, Vajpayee M, Prasad VV, Seth P. Genetic diversity of HIV type 1 subtype C env gene sequences from India. AIDS Res Hum Retroviruses 2007, 23:934-940. 10.1089/aid.2007.0036, 17678478.
    • (2007) AIDS Res Hum Retroviruses , vol.23 , pp. 934-940
    • Khan, I.F.1    Vajpayee, M.2    Prasad, V.V.3    Seth, P.4
  • 80
    • 68449087500 scopus 로고    scopus 로고
    • Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12
    • 10.1186/1742-4690-6-69, 2717910, 19619305
    • Dunfee RL, Thomas ER, Gabuzda D. Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12. Retrovirology 2009, 6:69. 10.1186/1742-4690-6-69, 2717910, 19619305.
    • (2009) Retrovirology , vol.6 , pp. 69
    • Dunfee, R.L.1    Thomas, E.R.2    Gabuzda, D.3
  • 81
    • 69449095991 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 escape from cyclotriazadisulfonamide-induced CD4-targeted entry inhibition is associated with increased neutralizing antibody susceptibility
    • 10.1128/JVI.00648-09, 2738218, 19570853
    • Vermeire K, Van Laethem K, Janssens W, Bell TW, Schols D. Human immunodeficiency virus type 1 escape from cyclotriazadisulfonamide-induced CD4-targeted entry inhibition is associated with increased neutralizing antibody susceptibility. J Virol 2009, 83:9577-9583. 10.1128/JVI.00648-09, 2738218, 19570853.
    • (2009) J Virol , vol.83 , pp. 9577-9583
    • Vermeire, K.1    Van Laethem, K.2    Janssens, W.3    Bell, T.W.4    Schols, D.5
  • 83
    • 33750036975 scopus 로고    scopus 로고
    • The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia
    • 10.1073/pnas.0605513103, 1586182, 17015824
    • Dunfee RL, Thomas ER, Gorry PR, Wang J, Taylor J, Kunstman K, Wolinsky SM, Gabuzda D. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc Natl Acad Sci USA 2006, 103:15160-15165. 10.1073/pnas.0605513103, 1586182, 17015824.
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 15160-15165
    • Dunfee, R.L.1    Thomas, E.R.2    Gorry, P.R.3    Wang, J.4    Taylor, J.5    Kunstman, K.6    Wolinsky, S.M.7    Gabuzda, D.8
  • 84
    • 2942687021 scopus 로고    scopus 로고
    • Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages
    • 10.1128/JVI.78.13.6915-6926.2004, 421670, 15194768
    • Peters PJ, Bhattacharya J, Hibbitts S, Dittmar MT, Simmons G, Bell J, Simmonds P, Clapham PR. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J Virol 2004, 78:6915-6926. 10.1128/JVI.78.13.6915-6926.2004, 421670, 15194768.
    • (2004) J Virol , vol.78 , pp. 6915-6926
    • Peters, P.J.1    Bhattacharya, J.2    Hibbitts, S.3    Dittmar, M.T.4    Simmons, G.5    Bell, J.6    Simmonds, P.7    Clapham, P.R.8
  • 86
    • 0035139698 scopus 로고    scopus 로고
    • Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection
    • 10.1089/08892220150217229, 11177393
    • Parekh BS, Pau CP, Kennedy MS, Dobbs TL, McDougal JS. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Res Hum Retroviruses 2001, 17:137-146. 10.1089/08892220150217229, 11177393.
    • (2001) AIDS Res Hum Retroviruses , vol.17 , pp. 137-146
    • Parekh, B.S.1    Pau, C.P.2    Kennedy, M.S.3    Dobbs, T.L.4    McDougal, J.S.5
  • 87
    • 23044447788 scopus 로고    scopus 로고
    • Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries
    • 10.1097/01.aids.0000172874.90133.7a, 15930838
    • McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, Marsh K, Wiktor SZ. Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. Aids 2005, 19(Suppl 2):S25-30. 10.1097/01.aids.0000172874.90133.7a, 15930838.
    • (2005) Aids , vol.19 , Issue.SUPPL. 2
    • McDougal, J.S.1    Pilcher, C.D.2    Parekh, B.S.3    Gershy-Damet, G.4    Branson, B.M.5    Marsh, K.6    Wiktor, S.Z.7
  • 88
    • 38149079942 scopus 로고    scopus 로고
    • Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin
    • 10.1089/aid.2007.0214, 18275353
    • Lakhashe S, Tripathy S, Paranjape R, Bhattacharya J. Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin. AIDS Res Hum Retroviruses 2008, 24:92-99. 10.1089/aid.2007.0214, 18275353.
    • (2008) AIDS Res Hum Retroviruses , vol.24 , pp. 92-99
    • Lakhashe, S.1    Tripathy, S.2    Paranjape, R.3    Bhattacharya, J.4
  • 89
    • 0036090585 scopus 로고    scopus 로고
    • Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
    • 10.1128/AAC.46.6.1896-1905.2002, 127242, 12019106
    • Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002, 46:1896-1905. 10.1128/AAC.46.6.1896-1905.2002, 127242, 12019106.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 1896-1905
    • Wei, X.1    Decker, J.M.2    Liu, H.3    Zhang, Z.4    Arani, R.B.5    Kilby, J.M.6    Saag, M.S.7    Wu, X.8    Shaw, G.M.9    Kappes, J.C.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.